Yupeng He

发表

Detection and Independent Validation of Model-Based Quantitative Transcriptional Regulation Relationships Altered in Lung Cancers

F. Zhou, M. Duan, H. Song, 2020, Frontiers in Bioengineering and Biotechnology.

Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer A C

Jeffrey W. Clark, G. Boland, D. Ryan, 2021 .

Analytical validation of a tissue agnostic ctDNA MRD assay using tumor specific methylation and somatic variant profiles in early-stage CRC.

Oscar Westesson, C. Artieri, A. Jaimovich, 2020 .

Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

Jeffrey W. Clark, B. Miao, G. Boland, 2021, Clinical Cancer Research.

Multimodal circulating tumor DNA (ctDNA) colorectal neoplasia detection assay for asymptomatic and early-stage colorectal cancer (CRC).

H. Kim, A. Jaimovich, Jeeyun Lee, 2021 .

Abstract 916: Combined genomic and epigenomic assessment of cell-free circulating tumor DNA (ctDNA) improves assay sensitivity in early-stage colorectal cancer (CRC)

Joon-Oh Park, H. Kim, E. Zotenko, 2019, Clinical Research (Excluding Clinical Trials).

S130 Multimodal Circulating Tumor DNA (ctDNA) Blood-Based Colorectal Cancer (CRC) Screening Test Demonstrates Clinically Meaningful Sensitivity Across Multiple Clinical Parameters

H. Kim, A. Jaimovich, Jeeyun Lee, 2021, American Journal of Gastroenterology.

Abstract 2316: Integrated genomic and epigenomic cell-free DNA (cfDNA) analysis for the detection of early-stage colorectal cancer

E. Zotenko, W. Greenleaf, Oscar Westesson, 2020 .

Minimal Residual Disease Detection using a Plasma-Only Circulating Tumor DNA Assay in Colorectal Cancer Patients

Jeffrey W. Clark, Qadan, Ariel, 2021 .